| Filed On | Filing |
|---|---|
| 12 Jun 2023 | CORE LABORATORIES NV |
| 12 May 2023 | 15F-12G |
| 02 May 2023 | 25-NSE |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 02 May 2023 | S-8 POS |
| 28 Apr 2023 | DEFA14A |
| 28 Apr 2023 | DEF 14A |
| 27 Apr 2023 | 10-Q |
| 26 Apr 2023 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 04 Apr 2023 | 8-K: Submission of Matters to a Vote of Security Holders |
| 03 Apr 2023 |
Form 4: van Dijken Eeuwijk Monique, Director
Received 5,485 shares by exercise or conversion |
| 03 Apr 2023 |
Form 4: Temeng Kwaku, Director
Received 5,485 shares by exercise or conversion · Granted 6,419 Restricted Shares |
Loading...
